Skills this job asks for
Lean / Six SigmaGoogle CloudAudit
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 2 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Feb 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
What Corcept Therapeutics INC paid sponsored hires in similar roles1 certified filing for “Director, Clinical Patient Safety & PV Ops” (Regulatory Affairs Managers) in CA: $245k–$245k, median $245k.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 2 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Feb 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Corcept Therapeutics INC paid sponsored hires in similar roles
- 1 certified filing for “Director, Clinical Patient Safety & PV Ops” (Regulatory Affairs Managers) in CA: $245k–$245k, median $245k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases.
Our commercial portfolio includes treatments for hypercortisolism and oncology, and the company has discovered more than 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists. With advanced clinical trials in patients with hypercortisolism, solid tumors, ALS and liver disease, Corcept is unlocking the power of cortisol modulation to help address some of the most devastating diseases patients face today.
Corcept is headquartered in Redwood City, California. To learn more, visit www.corcept.com .
The Senior Clinical Trial Manager (Sr. CTM) will play a key role in shaping and scaling Corcept’s clinical operations processes and SOP framework. This position may also independently manage operational aspects of clinical study. This leader will work with cross-functional teams as well as vendors, clinical sites, and CROs to execute protocol requirements to ensure study deliverables, milestones, and objectives are met within timelines and budget. This is a hybrid role that typically requires on-site presence three days per week.
Responsibilities:
• Proactively identify gaps in workflows and documentation, and designing scalable, inspection-ready SOPs and processes that enable high-quality study execution
• Author updates, and continuously improve SOPs, work instructions, templates, and forms to ensure they are lean, practical, and aligned with ICH-GCP E6 (R2/R3) standards
• Evaluate the downstream impact of SOP and process changes on ongoing trials, vendor contracts, and clinical systems (e.g., CTMS), ensuring seamless adoption without disrupting active programs
• Facilitate cross-functional SOP review and working groups
• Contribute to SOP governance, inspection readiness, and continuous improvement initiatives that strengthen Corcept’s clinical operations infrastructure
• Execute assigned clinical protocol with high quality according to Corcept SOPs, ICH/GCP, and corporate and departmental program goals
• Serve as a study lead to the multifunctional team to ensure clinical study/studies activities including study start-up, enrollment, maintenance, and close-out are executed per timeline and budget
• Work with Clinical Development and/or Medical Writing to generate clinical trial protocol synopsis, protocols, and protocol amendments
• Facilitate the CRO/Vendor selection process for outsourced activities, including developing an RFP, managing the bidding process, analysis of proposals, budgets, and leading and documenting vendor selection decisions. This includes review of cope of ork, budgets, and negotiating contracts through execution
• Procure and manage contracts with CROs, study vendors, and investigative sites
• Develop critical study documents, including informed consent form templates, various management plans, and study trackers
• Develop study timelines and budgets per the corporate and departmental goals and continuously strive to ensure timelines are deliverables are met within budget
• Develop, distribute, review, and track essential trial documents and/or oversee CRO responsibility for essential documents
• Provide Regulatory with Site Essential Regulatory Documents for submission to the FDA and other regulatory agencies
• Manage or provide oversight of CROs, independent field monitors, and other clinical vendors
• Ensure monitoring trip reports are reviewed and track resolution of all action items and protocol deviations
• Manage, either directly or through supervised delegation, other study-wide activities such as external vendors, sample handling, drug re-supply, investigator payments, data qual
Apply on employer site ↗